Neuroprotection and hypothermia in infants and children

Domenico Pietrini1, Marco Piastra, Ersilia Luca

  • 1Pediatric Intensive Care Unit, University Hospital “A.Gemelli”, Università Cattolica del Sacro Cuore, Rome, Italy. d.pietrini@rm.unicatt.it

Current Drug Targets
|April 20, 2012
PubMed

Insights

Therapeutic hypothermia (TH) effectively treats brain injuries in children, including after cardiac arrest, hypoxic-ischemic encephalopathy, and traumatic brain injury. It reduces harmful processes like inflammation and excitotoxicity, offering a vital treatment option.

Area of Science:

  • Neurology
  • Pediatric Critical Care
  • Neuroprotection

Background:

  • Brain injury is a leading cause of death in pediatric intensive care units.
  • Therapeutic hypothermia (TH) is established for specific pediatric neurological emergencies.
  • Emerging evidence suggests broader applications for TH in critical care settings.

Purpose of the Study:

  • To review the current literature on the use of therapeutic hypothermia in pediatric critical care.
  • To highlight the neuroprotective mechanisms of TH in various brain injury models.
  • To discuss the potential of TH as an adjunctive therapy for refractory neurological conditions.

Main Methods:

  • Literature review of studies on therapeutic hypothermia in pediatric populations.
  • Analysis of clinical evidence for TH in cardiac arrest, hypoxic-ischemic encephalopathy, and traumatic brain injury.
  • Examination of preclinical data on TH's impact on neuroinflammatory and apoptotic pathways.

Main Results:

  • TH is beneficial for unconscious patients post-cardiac arrest with ventricular fibrillation.
  • TH has demonstrated efficacy in term neonates with hypoxic-ischemic encephalopathy.
  • TH shows promise in children with traumatic brain injury and superrefractory status epilepticus.

Conclusions:

  • Therapeutic hypothermia mitigates critical neurodestructive processes following ischemia-reperfusion injury.
  • TH offers a valuable therapeutic option, particularly when conventional treatments for elevated intracranial pressure are insufficient.
  • Further research is warranted to optimize TH protocols and expand its clinical utility in pediatric neurology.

Related Concept Videos